Joseph Walker
Reporter at The Wall Street Journal @WSJ. Hello in there, hello. Mail: 1211 Ave. of the Americas, 5th Fl, NY, NY 10036
Last synced from Twitter Not synced yet
To Find a Coronavirus Vaccine, GlaxoSmithKline Is Bonding With Its Biggest Competitors
The hunt for a solution to Covid-19 is producing an unlikely team of rivals in the cutthroat world of pharmaceuticals.
WHO-Backed Study Finds No Remdesivir Benefit for Hospitalized Covid-19 Patients
The findings add to debate over the utility of the medicine developed by Gilead Sciences in treating the new coronavirus.
Vertex Shares Plunge After Biotech Drops Closely Watched Drug Prospect
The flop of a promising drug from Vertex Pharmaceuticals led to a sharp drop in the company’s share price on Thursday as analysts questioned the biotech’s ability to replicate its success in cystic fibrosis and diversify its revenue.
Study of Eli Lilly Covid-19 Drug Paused Due to Safety Concern
A federally funded clinical trial testing an experimental Eli Lilly & Co. Covid-19 treatment has been paused due to a potential safety concern, the company said.
Antibody Drugs Touted by Trump Could Be Next to Get Authorized for Covid-19
President Trump’s endorsement of an experimental Covid-19 drug from Regeneron Pharmaceuticals has raised expectations for a type of medicine that could be authorized for public use within weeks or even days.
Takeda, Other Firms Test Covid-19 Convalescent-Plasma Treatment
The experimental treatment for hospitalized Covid-19 patients is derived from the convalescent plasma of people who have recovered from the new coronavirus.
Trump’s Covid-19 Steroid Treatment Breaks From Norm, Doctors Say
The president’s doctors appear to be administering dexamethasone earlier in the course of treatment than they would with other patients, say physicians experienced in treating Covid-19.
Trump’s Weight, Age, Gender Make Severe Covid-19 More Likely
The risk for a severe case of Covid-19 increases with age, along with factors including whether a person has other medical conditions like cancer, diabetes or obesity, studies show.
Regeneron Drug Found to Help Treat Covid-19 in Early Disease Stage
The drugmaker said a preliminary analysis of clinical-trial data showed reduced virus levels in nonhospitalized Covid-19 patients.
Covid-19 Deaths Significantly Reduced by Use of Steroids, Analysis Says
In multiple studies involving a total of 1,700 patients, a number of anti-inflammatory drugs helped reduce deaths from Covid-19 by about a third, compared with patients who didn’t receive steroids, according to a newly published analysis.
1
Joseph Walker
Cheap steroids reduce Covid-19 deaths in the sickest hospitalized patients
177d
Antibody Drugs Advancing to Fill Covid-19 Treatment Gap
A kind of drug that takes a page from a body’s natural antibody defenses may be able to give many people early protection against the coronavirus, ahead of vaccines.
Regeneron Enlists Swiss Rival Roche to Help Make Covid-19 Drug
Roche has agreed to help manufacture and distribute a promising investigational drug—code named REGN-COV2—being developed by Regeneron, a pairing of rivals that could more than triple supplies of the medicine if it is authorized by regulators.
America’s Superdense Foreign Policy Black Hole
Why Donald Trump should defy the elites and get the U.S. forces out of Afghanistan
1
Joseph Walker
“After two decades, more than 2,300 American lives lost, and some $2 trillion spent, the Taliban is stronger than ever.”
America’s Superdense Foreign Policy Black Hole - Tablet Magazine
205d
Covid-19 Vaccine Front-Runners Impress Investors, but Concerns Exist
Gene-based vaccines from Moderna, Pfizer and its partner BioNTech are drawing early enthusiasm, but investors are leery because valuations have soared.
Sanofi, GlaxoSmithKline Ink Coronavirus Vaccine Deal With U.S.
The U.S. will pay up to $2.1 billion to Sanofi and GlaxoSmithKline to fund the development of a coronavirus vaccine and guarantee supply of 100 million doses, if proven safe and effective in clinical trials, the companies said.
Genentech: Press Releases | Tuesday, Jul 28, 2020
Discover the latest news about our company, our products, our policies, and our people.
1
Joseph Walker
Genentech's Actemra fails to improve Covid-19 symptoms or reduce deaths in phase 3 trial, another disappointment for IL-6/cytokine storm hypothesis gene.com/media/press-re… pic.twitter.com/h665fhqASR
212d
Regeneron Advances Covid-19 Drug Into Later-Stage Testing
Regeneron is starting later-stage studies of its experimental Covid-19 drug, a quick move into testing that could establish whether the drug can be used for treatment and prevention.
U.S. Commits $2 Billion for Covid-19 Vaccine, Drug Supplies
The federal government awarded $2 billion to two drugmakers to support development and manufacturing of an experimental drug and a potential vaccine against Covid-19.
Arthritis Drug Fails in Study of Covid-19 Patients
Regeneron Pharmaceuticals and Sanofi said their arthritis drug Kevzara failed to help Covid-19 patients recover in a U.S. clinical trial.
Covid-19 Drug Remdesivir to Cost $3,120 for Typical Patient
Gilead Sciences disclosed its pricing plans as it prepares to begin charging for remdesivir in July. The U.S. has been distributing the drug donated by Gilead since it was authorized for emergency use in May.